Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats

American Journal of Pathology

Volumn 165, Issue 1, 2004, Pages 299-307

  Kapoor, Mohit ^a   Howard, Rowena ^a   Hall, Irene ^a   Appleton, Ian ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; COLLAGEN FIBER; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPICATECHIN GALLATE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRITE; SODIUM CHLORIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SCAR FORMATION; SKIN INCISION; UPREGULATION; WESTERN BLOTTING; WOUND; WOUND HEALING;

EID: 3042643600     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63297-X     Document Type: Article

References (39)

1. Appleton I: Wound healing: future directions. Invest Drugs 2003, 6:1067-1072
2. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995, 146:1029-1039
3. Norrby K: Angiogenesis: new aspects relating to its initiation and control. Acta Pathol Microbiol Immunol Scand 1997, 105:417-437
4. Chan MM-Y, Dunne F, Ho C-T, Huang H-I: Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem Pharmacol 1999, 54:1281-1286
5. Yen GC, Chen HY: Scavenging effect of various tea extracts on superoxide derived from the metabolism of mutagens. Biosci Biotech Biochem 1998, 62:1768-1770
6. Katiyar SK, Matsui MS, Elmets CA, Mukhtar H: Polyphenolic antioxidant epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol 1999, 69:148-153
7. Yang F, de Villiers WJ, McClain CJ, Varilek GW: Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 1998, 128:2334-2340
8. Crouvezier S, Powell B, Keir D, Yaqoob P: The effects of phenolic components of tea on the production of Pro- and anti-inflammatory cytokines by human leukocytes in vitro. Cytokine 2000, 13:280-286
9. Isemura M, Saeki K, Minami T, Hayakawa S, Kimura T, Shoji Y, Sazuka M: Inhibition of matrix metalloproteinases by tea catechins and related polyphenols. Ann NY Acad Sci 1999, 30:629-631
10. Frampton L, Rahman R, Bolger C, Hall I, Appleton I: The effects of catechins on a murine model of chronic granulomatous inflammation. Proceedings of the Australian Health Medical Research Congress, Melbourne, National Health and Medical Research Council, November 25-29, 2002, p 2030
11. Caturla N, Vera-Samper Villalaín J, Reyes Mateo C, Micol V: The relationship between the antioxidant and the antibacterial properties of galloylated catechins and the structure of phospholipid model membranes. Free Rad Biol Med 2003, 34:648-662
12. Appleton I, Brown NJ, Willis D, Colville-Nash PR, Alam C, Brown JR, Willoughby DA: The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J Pathol 1996, 180:90-94
13. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Ann Biochem 1979, 72:248-254
14. Jude E, Boulton A, Ferguson MWJ, Appleton I: The role of nitric: oxide synthase and arginase in diabetic foot ulceration: modulatory effects of transforming growth factor beta. Diabetalogia 1999, 42:748-757
15. Greenhalgh DG: The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998, 30:1019-1030
16. Tredget EE, Nedelec B, Scott PG, Ghahary A: Hypertropic scars, keloids, and contractures: the cellular and molecular basis for therapy. Surg Clin North Am 1997, 77:701-730
17. Most D, Efron DT, Shi HP, Tantry US, Barbul A: Characterisation of incisional wound healing in inducible nitric oxide synthase knockout mice. Surgery 2002, 132:866-876
18. Appleton I, Tomlinson A, Willoughby DA: Induction of cyclooxygenase and nitric-oxide synthase in inflammation. Adv Pharmacol 1996, 35:27-78
19. Abd-El-Aleem S, Ferguson MWJ, Appleton I, Kairsingh S, Jude E, Jones K, McCollum C, Ireland G: Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol 2000, 191:434-442
20. Folkman J, Shing Y: Angiogenesis: a mini review. J Biol Chem 1992, 267:10931-10934
21. Ferrara N: Vascular endothelial growth factor and the regulation of angiogenesis. Rec Prog Horm Res 2000, 55:15-35
22. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Dhiarugi V, Masisni E: Cylooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 2001, 3:53-61
23. Frank S, Kampfer H, Wetzler C, Pfeilschifter J: Nitric oxide drives skin repair: novel functions of an established mediator. Kidney Int 2002, 61:882-888
24. Zhang J, Snyder SH: Nitric oxide in the nervous system. Annu Rev Pharmacol Toxicol 1995, 35:213-233
25. Frank S, Stallmeyer B, Kampfer H: Nitric Oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J 1999, 13:2002-2014
26. Noiri E, Lee E, Testa J, Quigley J, Colflesh D, Keese CR, Giaever I, Goligorsky MS: Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol 1998, 247:C236-C244
27. Shi HP, Efron DT, Most D, Barbul A: The role of iNOS in wound healing. Surgery 2001, 130:225-229
28. Schaffer MR, Efron PA, Thorton FJ: Nitric oxide: an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997, 158:2375-2381
29. Ferrini MG, Vernet D, Magee TR, Shahed A, Qian A, Rajfer J, Gonzalez-Cadavid NF: Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide Biol Chem 2002, 6:283-294
30. White MB, Thorton FJ, Efron DT: Enhancement of fibroblast collagen synthesis by nitric oxide. Nitric Oxide 2000, 4:572-582
31. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA: Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999, 5:698-701
32. 2 on wound healing in rats. Ann Clin Lab Sci 1996, 26:451-457
33. Sanchez T, Moreno JJ: Role of phospholipase A (2) in growth-dependant changes in prostaglandin release from 3T3 fibroblasts. J Cell Physiol 2001, 189:237-243
34. 1 in osteoblasts. J Clin Invest 1994, 93: 2490-2496
35. Ben-Av P, Crofford LJ, Wilder RL, Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1 A potential mechanism of inflammatory angiogenesis. FEBS Lett 1995, 372:83-87
36. Wiesinger H: Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 2001, 64:365-391
37. Wu G, Morris SM: Arginine metabolism: nitric oxide and beyond. Biochem J 1998, 336:1-17
38. Hui Li, Cynthia J. Meininger, James R. Hawker Jr, Tony E Haynes, Diane Kepka-Lenhart, Sanjay K Mistry, Sidney M Morris Jr, and Guoyao Wu: regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells Am J Physiol Endocrinol Metab 2001, 280:E75-E82
39. Witte M, Barbul A, Schick M, Vogt N, Becker HD: Upregulation of arginase expression in wound-derived fibroblasts. J Surg Res 2002, 105:35-42